PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Yingxun Luo

Shantou Central Hospital

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · JOURNAL ARTICLE

Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data

Frontiers in Pharmacology

Pharmacovigilance analysis of 2,486 real-world adverse event reports confirming known safety differences between drug classes with clear disproportionality signals, but observational and hypothesis-generating rather than practice-changing in design.

Important Confirmatory EvidenceProstate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Yingxun Luo

Reported

Total reports analysed2,486

GnRH antagonist reports444

GnRH agonist reports2,042

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support